483
Glenmark Pharmaceuticals LimitedFDA 483 - Glenmark Pharmaceuticals Limited - September 27, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Glenmark Pharmaceuticals Limited, a non-sterile drug manufacturer in Colvale Bardez, Goa, India, revealed two significant observations. The firm failed to adequately correct a previous observation regarding cleaning documentation for equipment and utensils. Additionally, production and process control procedures were not followed, leading to unsealed drums of in-process material.
Open in Dashboard
ID · 1b6b5a08-12ee-4621-95d3-64968e415cc1